|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses: | |
| Research and development | |
| Selling, general and administrative | |
| Total operating expenses | |
| Income (loss) from operations | |
| Other income (expense): | |
| Interest income | |
| Interest expense | |
| Net gain on extinguishment of debt | |
| Change in fair value of term loan | |
| Change in fair value of convertible notes | |
| Other expense, net | |
| Total other income (expense) | |
| Income (loss) before provision for income taxes | |
| Total provision for income taxes | |
| Net income (loss) | |
| Less: Net income (loss) attributable to participating securities | |
| Net income (loss) attributable to common stockholders | |
| Other comprehensive loss, net of taxes: | |
| Change in fair value of term loan attributable to instrument‑specific credit risk | |
| Other comprehensive loss, net of taxes | |
| Comprehensive income (loss), net of taxes | |
| Net income (loss) per share attributable to common stockholders, basic and diluted: | |
| Net income (loss) per share, basic (in dollars per share) | |
| Net income (loss) per share, diluted (in dollars per share) | |
| Weighted-average shares used in calculating net income (loss) per share attributable to common stockholders, basic and diluted: | |
| Weighted-average shares used in calculating net income (loss) per share, basic (in shares) | |
| Weighted-average shares used in calculating net income (loss) per share, diluted (in shares) |
Loading...
